An Updated View On Upcoming Treatments

MrV88

Senior Member
My Regimen
Reaction score
1,242
All involves much money and flying to japan and probably waiting in a 10-year queue. I would kill for this though.
Try killing FOR it and not yourself.

The day we lose our hope around here is probably the day that we kill ourselves. Still better than nothing in your special case
 

Georgie

Senior Member
My Regimen
Reaction score
2,721
Try killing FOR it and not yourself.

The day we lose our hope around here is probably the day that we kill ourselves. Still better than nothing in your special case
I feel like I will have given up by the time all this stuff is available.
 

Iah11

Established Member
My Regimen
Reaction score
323
I realise I've actually missed a couple of important things.

PolarityTE is an unknown quantity. It aims to regenerate wounded skin to take on the appearance of the healthy surrounding skin (of which a biopsy has been taken to create the 'new' skin). Their preclinical research showed success in pigs and it is confirmed to be in use in several US hospitals. The use of autologous cells means the treatment skips typical phase 1/2/3 testing. Interestingly, they have claimed that initial human results have shown the regeneration of full thickness "hair-bearing" skin. They are on record saying they will pursue a hair related product. We dont really know though. They are aiming to release clinical data in the next 3 months. The science is solid, preclinical data is solid, recent acquisition of a new 700,000 square foot facility, publicly traded company.

Honestly at this point, a 5 year timeline seems pessimistic for a new treatment to come out.
 

Timii

Experienced Member
My Regimen
Reaction score
520
I realise I've actually missed a couple of important things.

PolarityTE is an unknown quantity. It aims to regenerate wounded skin to take on the appearance of the healthy surrounding skin (of which a biopsy has been taken to create the 'new' skin). Their preclinical research showed success in pigs and it is confirmed to be in use in several US hospitals. The use of autologous cells means the treatment skips typical phase 1/2/3 testing. Interestingly, they have claimed that initial human results have shown the regeneration of full thickness "hair-bearing" skin. They are on record saying they will pursue a hair related product. We dont really know though. They are aiming to release clinical data in the next 3 months. The science is solid, preclinical data is solid, recent acquisition of a new 700,000 square foot facility, publicly traded company.

Honestly at this point, a 5 year timeline seems pessimistic for a new treatment to come out.
It's like life is challenging me to maintain my hair until new treatments come out
 

That Guy

Banned
My Regimen
Reaction score
5,361
Yeah but I also have menopausal style body hair thinning. All over my body.

You've probably said somewhere, but have you been to a doctor about that?

I mean, that just seems like there's a deeper problem than garden-variety hairloss if you're losing body hair as well.
 

Georgie

Senior Member
My Regimen
Reaction score
2,721
You've probably said somewhere, but have you been to a doctor about that?

I mean, that just seems like there's a deeper problem than garden-variety hairloss if you're losing body hair as well.
Yes I have and I’ve been diagnosed. It’s a fairly easy concept to grab. When sex hormones decline, body hair gets thinner, when you don’t have enough estrogen to counteract androgens, your scalp hair gets thinner.
 

Willy Shakespeare

New Member
My Regimen
Reaction score
29
This is my personal idea for dupa patients and the cure. So dht grows hair for every single body part except for hair. So for dupa patients, what if tsuji and reprlicel duplicate beard or any other hair that’s not from head. And they inject into the hair and it will grow much more easily and thick. It just my thought. Since it’s possible to transplant hairs from body part to head.

I desire thou art right, mate! I tenderly comb mine pubic hair everyday with that desire...
 

GVTAR

New Member
My Regimen
Reaction score
1
I realise I've actually missed a couple of important things.

PolarityTE is an unknown quantity. It aims to regenerate wounded skin to take on the appearance of the healthy surrounding skin (of which a biopsy has been taken to create the 'new' skin). Their preclinical research showed success in pigs and it is confirmed to be in use in several US hospitals. The use of autologous cells means the treatment skips typical phase 1/2/3 testing. Interestingly, they have claimed that initial human results have shown the regeneration of full thickness "hair-bearing" skin. They are on record saying they will pursue a hair related product. We dont really know though. They are aiming to release clinical data in the next 3 months. The science is solid, preclinical data is solid, recent acquisition of a new 700,000 square foot facility, publicly traded company.

Honestly at this point, a 5 year timeline seems pessimistic for a new treatment to come out.


From their website

"If successful in the burn market, we plan to explore entry into other markets, such as acute and chronic wounds, cosmetic/scar revisions, and hair regeneration."

Emphasis added
 

Jesse Navarro

Established Member
My Regimen
Reaction score
115
Get out of here Willy, look at my beautiful hair. Envy me.

christopher-marlowe-wc-9399572-1-402.jpg
 

Iah11

Established Member
My Regimen
Reaction score
323
From their website

"If successful in the burn market, we plan to explore entry into other markets, such as acute and chronic wounds, cosmetic/scar revisions, and hair regeneration."

Emphasis added

Interesting. Theres an interview from last year in which a member of their team states they were already working on optimising a hair loss product. I would like to know why the product couldnt be used after a FUT procedure to heal the scar, with added hair. Like a hair cloning product?

Also added note: the Tsuji Organ Regeneration website actually states trials are being targeted for this year. Theyre very confident in their tech it seems.
 

baldco

Member
My Regimen
Reaction score
38
Tbh, JAK inhibitors have been tried at high doses for a while, even orally, for other conditions. JAK-STAT signalling is definitely altered in Androgenetic Alopecia, but I fail to see them being very successful. I could be wrong of course.
.

I think this is only published 2 days ago, I can't find this on sci-hub. Involves JAK-STAT5
From
Author(s):Wang, Etienne Cho Ee
Thesis Advisor(s): Christiano, Angela M.
Date: March 2018

"distinct subset of TREM2+ macrophages predominate during early- and mid-telogen, where they produce Oncostatin M (OSM), which is sufficient to maintain quiescence of hair follicle stem cells (HFSCs). Proliferation of HFSCs and hair growth is associated with depletion of this subset of TREM2+ macrophages. Interestingly, macrophage markers and OSM were found to be upregulated in the balding scalp of males with androgenetic alopecia, suggesting that this mechanism is physiologically relevant in the control of human hair cycling."


"The mechanism through which OSM exerts this effect is via JAK-STAT5 signaling downstream of the OSM receptor, which is antagonized by pharmacological JAK inhibition. Conditional epidermal ablation of OSMR or STAT5 during early- and mid-telogen (P42 – P60) shortens the telogen phase significantly, and inhibition of macrophages by way of neutralizing antibodies, small molecule inhibitors, and genetic ablation (with Csf1r-CreER::R26-iDTR mice) during telogen also promotes hair growth. "


I know Folicium is doing something with OSM and had good results
 
Last edited:

dermrafok

Established Member
My Regimen
Reaction score
512
Aclaris experimental hair loss treatment gets additional patent protection

https://www.bizjournals.com/philade...-hair-loss-jak-inhibitor-patent-columbia.html

U.S. patent number 9,895,301 covers the use of tofacitinib, a JAK inihibitor, for inducing hair growth and for treating hair loss disorders such as alopecia areata and androgenetic alopecia — otherwise known as male/female pattern hair loss.

Current treatments are so ineffective that's why the market fiercely launches into new treatments for androgenetic alopecia. That's....business...Just saying.
 
Last edited:

Georgie

Senior Member
My Regimen
Reaction score
2,721
Aclaris experimental hair loss treatment gets additional patent protection

https://www.bizjournals.com/philade...-hair-loss-jak-inhibitor-patent-columbia.html

U.S. patent number 9,895,301 covers the use of tofacitinib, a JAK inihibitor, for inducing hair growth and for treating hair loss disorders such as alopecia areata and androgenetic alopecia — otherwise known as male/female pattern hair loss.

Current treatments are so ineffective that's why the market fiercely launches into new treatments for androgenetic alopecia. That's....business...Just saying.
WE’LL TAKE THE LOT
 

Iah11

Established Member
My Regimen
Reaction score
323
I think this is only published 2 days ago, I can't find this on sci-hub. Involves JAK-STAT5
From
Author(s):Wang, Etienne Cho Ee
Thesis Advisor(s): Christiano, Angela M.
Date: March 2018

"distinct subset of TREM2+ macrophages predominate during early- and mid-telogen, where they produce Oncostatin M (OSM), which is sufficient to maintain quiescence of hair follicle stem cells (HFSCs). Proliferation of HFSCs and hair growth is associated with depletion of this subset of TREM2+ macrophages. Interestingly, macrophage markers and OSM were found to be upregulated in the balding scalp of males with androgenetic alopecia, suggesting that this mechanism is physiologically relevant in the control of human hair cycling."


"The mechanism through which OSM exerts this effect is via JAK-STAT5 signaling downstream of the OSM receptor, which is antagonized by pharmacological JAK inhibition. Conditional epidermal ablation of OSMR or STAT5 during early- and mid-telogen (P42 – P60) shortens the telogen phase significantly, and inhibition of macrophages by way of neutralizing antibodies, small molecule inhibitors, and genetic ablation (with Csf1r-CreER::R26-iDTR mice) during telogen also promotes hair growth. "


I know Folicium is doing something with OSM and had good results

Good find but this is why i struggle to have faith in a treatment such as a JAK inhibitor being better than finasteride. A JAK inbibitor will prevent this particular mechanism (shorter hair cycle) but how does it affect all the other pathological insults that arise from DHT binding the AR? In my view, succesful upcoming treatments for regrowth should focus on neogenesis/healing.
 

Iah11

Established Member
My Regimen
Reaction score
323
UPDATE ON THE OP

1) Follica pipeline was updated in the last few weeks. The bar has now completed Phase 2. Speculation that the pre pivotal trial has completed and that the beginning of phase 3 is very, very imminent.

2) RCH-01 was named as a key product in Shiseido's new three year plan to increase its revenues, on its website. It is stated "we will not only produce innovation in cosmetics but also build innovative business models and explore new frontiers such as artificial skin, hair and skin regeneration", showing that they haven't forgot about it but it's thought of as an important part of their plans to increase revenue. The trial is finished now. I'm pretty confident it will be out in 2019 at some point.

3) Brotzu is a scam.

4) Setipiprant data readout planned for March 2019, although I don't believe this will get released.

5) The Tsuji team released a press statement in which it is claimed all hurdles to hair multiplication in humans have now been solved in the lab (including the mythical inductivity problem) and this is ready to leave the preclinical stage. Human trials are definitively scheduled for March 2019, on the condition that the newly commenced mouse studies don't show carcinogenesis. This genuinely is the holy grail of hair loss and its tantalisingly close!

6) Surprisingly, no updates on PTD-DBM. There was a study released that showed the benefits of the substance with VPA. Still waiting on the conference in August, where the lead researcher is present. Hopefully a lot of new info there and ideally news of human trial..

Almost halfway through 2018 and everything is going... surprisingly well? Tsuji team no longer seems like a fantasy, Follica are still marching on, RCH-01 is being talked of positively by Shiseido, Samumed planning on an unexpected Phase 3. The end is near boys, we're so close now!!
 

AnArcticTaco

Established Member
My Regimen
Reaction score
235
UPDATE ON THE OP

1) Follica pipeline was updated in the last few weeks. The bar has now completed Phase 2. Speculation that the pre pivotal trial has completed and that the beginning of phase 3 is very, very imminent.

2) RCH-01 was named as a key product in Shiseido's new three year plan to increase its revenues, on its website. It is stated "we will not only produce innovation in cosmetics but also build innovative business models and explore new frontiers such as artificial skin, hair and skin regeneration", showing that they haven't forgot about it but it's thought of as an important part of their plans to increase revenue. The trial is finished now. I'm pretty confident it will be out in 2019 at some point.

3) Brotzu is a scam.

4) Setipiprant data readout planned for March 2019, although I don't believe this will get released.

5) The Tsuji team released a press statement in which it is claimed all hurdles to hair multiplication in humans have now been solved in the lab (including the mythical inductivity problem) and this is ready to leave the preclinical stage. Human trials are definitively scheduled for March 2019, on the condition that the newly commenced mouse studies don't show carcinogenesis. This genuinely is the holy grail of hair loss and its tantalisingly close!

6) Surprisingly, no updates on PTD-DBM. There was a study released that showed the benefits of the substance with VPA. Still waiting on the conference in August, where the lead researcher is present. Hopefully a lot of new info there and ideally news of human trial..

Almost halfway through 2018 and everything is going... surprisingly well? Tsuji team no longer seems like a fantasy, Follica are still marching on, RCH-01 is being talked of positively by Shiseido, Samumed planning on an unexpected Phase 3. The end is near boys, we're so close now!!

Is it possible we could see RCH-01 by the end of 2018?
 

ffar1989

Established Member
My Regimen
Reaction score
113
@lah11 you mean that Seti won't be release in 2019 or ever? Why?
 
Top